About Fumapharm
As of May 31, 2006, Fumapharm AG was acquired by Biogen Idec, Inc. Fumapharm AG, a pharmaceutical company, develops therapeutics. Its products include FUMADERM for the treatment of psoriasis; and BG-12 for the treatment of multiple sclerosis and psoriasis. The company was founded in 1983 and is headquartered in Luzern, Switzerland.
Facts about Fumapharm
Facts about Fumapharm
- Industry : Pharma
Here you will find Fumapharm AG
Last viewed contents
Survey: Hiding risks can hurt public support for nanotechnology
New research data highlight the potential of Basilea's BAL101553 as a novel oncology drug candidate
SI-special instruments GmbH - Nördlingen, Germany
Galapagos and Dart Neuroscience LLC sign drug discovery and compound management agreements
Galapagos announces PPAR-delta commercial license agreement with Hillcrest Therapeutics
Stolon
Dr. Simon Moroney Awarded Bavarian State Medal for Outstanding Services to the Bavarian Economy
FSM Elektronik GmbH - Kirchzarten, Germany
EPIRUS Biopharmaceuticals - Utrecht, Netherlands
BIOAXXESS - Tewkesbury, United Kingdom
